|

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

RECRUITINGSponsored by Jung-min Ahn
Actively Recruiting
SponsorJung-min Ahn
Started2022-09-01
Est. completion2026-12-31
Eligibility
Age19 Years+
View on ClinicalTrials.gov →

NCT05044273

Summary

The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.

Eligibility

Age: 19 Years+
Inclusion Criteria:

* Patients ≥ 19 years old
* Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s).
* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion Criteria:

* Patients with a mixture of other drug-eluting stents (DESs)
* Terminal illness with life-expectancy ≤1 year.
* Patients with cardiogenic shock

Conditions6

Cardiovascular DiseasesCoronary Artery DiseaseCoronary DiseaseHeart DiseaseHeart DiseasesMyocardial Ischemia

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.